Advertisement

Index by Author

May 1997; 46 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ablamunits, V

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  2. Ahren, B

    • Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes May 1997 46:801-807; doi:10.2337/diabetes.46.5.801

  3. Akots, G

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  4. Alessi, M C

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

  5. Allan, D J

    • Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes May 1997 46:750-757; doi:10.2337/diabetes.46.5.750

  6. Alzahabi, B

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  7. Anfossi, G

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  8. Araki, S

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

B

  1. Baldeón, M E

    • Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines. Diabetes May 1997 46:770-778; doi:10.2337/diabetes.46.5.770

  2. Baldi, S

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  3. Becher, T

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  4. Berden, J H

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  5. Birk, O S

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  6. Boden, G

    • Leptin is present in human cord blood. Diabetes May 1997 46:917-919; doi:10.2337/diabetes.46.5.917

  7. Bolli, G B

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  8. Boschetti, E

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  9. Bosia, A

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  10. Bottini, P

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  11. Bowden, D W

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  12. Bruijn, J A

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  13. Brunetti, P

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  14. Buschard, K

    • Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes May 1997 46:792-800; doi:10.2337/diabetes.46.5.792

C

  1. Cameron, D P

    • Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes May 1997 46:750-757; doi:10.2337/diabetes.46.5.750

  2. Carel, J C

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

  3. Carmi, P

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  4. Catalano, C

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  5. Cavalot, F

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  6. Ciofetta, M

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  7. Clausen, J O

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

  8. Cohen, I R

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  9. Cooke, A

    • Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes May 1997 46:779-784; doi:10.2337/diabetes.46.5.779

  10. Costamagna, C

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

D

  1. Daha, M R

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  2. Del Sindaco, P

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  3. Dembski, M

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  4. Deng, N

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  5. Ding, W G

    • Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes May 1997 46:792-800; doi:10.2337/diabetes.46.5.792

E

  1. El-Hag, O

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  2. Elias, D

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  3. Ellis, S J

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

F

  1. Ferrannini, E

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  2. Fischer, U

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  3. Freedman, B I

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  4. Freyse, E J

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  5. Fridberg, M

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

  6. Fujii, W

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  7. Fukagawa, N K

    • Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes May 1997 46:920-923; doi:10.2337/diabetes.46.5.920

G

  1. Gagné, J

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  2. Gaskins, H R

    • Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines. Diabetes May 1997 46:770-778; doi:10.2337/diabetes.46.5.770

  3. Gélinas, S

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  4. Ghigo, D

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  5. Gibb, I

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  6. Gimeno, C J

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  7. Gimeno, R E

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  8. Göke, B

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  9. Gromada, J

    • Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes May 1997 46:792-800; doi:10.2337/diabetes.46.5.792

H

  1. Habener, J F

    • Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes May 1997 46:785-791; doi:10.2337/diabetes.46.5.785

  2. Haneda, M

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

  3. Hansen, T

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

  4. Harmon, B V

    • Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes May 1997 46:750-757; doi:10.2337/diabetes.46.5.750

  5. Havel, P J

    • Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes May 1997 46:801-807; doi:10.2337/diabetes.46.5.801

  6. Hayashi, T

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  7. Heller, R S

    • Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes May 1997 46:785-791; doi:10.2337/diabetes.46.5.785

  8. Henry, M

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

  9. Holers, M V

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

  10. Homko, C J

    • Leptin is present in human cord blood. Diabetes May 1997 46:917-919; doi:10.2337/diabetes.46.5.917

  11. Hosokawa, Y A

    • Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats. Diabetes May 1997 46:808-813; doi:10.2337/diabetes.46.5.808

  12. Howard, T D

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  13. Hughes, V

    • Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes May 1997 46:920-923; doi:10.2337/diabetes.46.5.920

  14. Hutchings, P

    • Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes May 1997 46:779-784; doi:10.2337/diabetes.46.5.779

I

  1. Ikeda, T

    • A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes May 1997 46:887-894; doi:10.2337/diabetes.46.5.887

  2. Inoue, G

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  3. Iris, F

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  4. Ishikawa, S

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  5. Isono, M

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

J

  1. Ji, L

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876

  2. Juhan-Vague, I

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

K

  1. Kapoor, S

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  2. Kawata, T

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  3. Kayo, T

    • A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes May 1997 46:887-894; doi:10.2337/diabetes.46.5.887

  4. Kerr, D

    • Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes May 1997 46:829-833; doi:10.2337/diabetes.46.5.829

  5. Kieffer, T J

    • Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes May 1997 46:785-791; doi:10.2337/diabetes.46.5.785

  6. Kikkawa, R

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

  7. Knospe, S

    • Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs. Diabetes May 1997 46:824-828; doi:10.2337/diabetes.46.5.824

  8. Koike, T

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  9. Koizumi, A

    • A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes May 1997 46:887-894; doi:10.2337/diabetes.46.5.887

  10. Könen-Waisman, S

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  11. Kosaki, A

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  12. Krolewski, A S

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876

  13. Kurnik, B R

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  14. Kurnik, P B

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  15. Kuzuya, H

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

L

  1. Lahsaïni, A

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  2. Leahy, J L

    • Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats. Diabetes May 1997 46:808-813; doi:10.2337/diabetes.46.5.808

  3. Liang, P

    • Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes May 1997 46:920-923; doi:10.2337/diabetes.46.5.920

  4. Lin, W M

    • Leptin is present in human cord blood. Diabetes May 1997 46:917-919; doi:10.2337/diabetes.46.5.917

M

  1. Makita, Z

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  2. Malecki, M

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876

  3. Martinoli, M G

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  4. Masoni, A

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  5. Massicotte, G

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  6. Massucco, P

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  7. Mattiello, L

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  8. McGowan, T A

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  9. Meilin, A

    • Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes May 1997 46:758-764; doi:10.2337/diabetes.46.5.758

  10. Milot, M

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

  11. Monaco, J J

    • Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines. Diabetes May 1997 46:770-778; doi:10.2337/diabetes.46.5.770

  12. Morange, P

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

  13. Mularoni, E

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  14. Murphy, J

    • Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes May 1997 46:829-833; doi:10.2337/diabetes.46.5.829

  15. Muscelli, E

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  16. Møller, A M

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

N

  1. Nakamura, S

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  2. Nakao, K

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  3. Nalbone, G

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

  4. Nandi, D

    • Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines. Diabetes May 1997 46:770-778; doi:10.2337/diabetes.46.5.770

  5. Neece, D J

    • Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines. Diabetes May 1997 46:770-778; doi:10.2337/diabetes.46.5.770

O

  1. O'Brien, B A

    • Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes May 1997 46:750-757; doi:10.2337/diabetes.46.5.750

  2. Okamoto, M

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

P

  1. Pampanelli, S

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  2. Pedersen, O

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

  3. Peiretti, F

    • Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes May 1997 46:860-867; doi:10.2337/diabetes.46.5.860

  4. Piretto, V

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

Q

  1. Qadri, A

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  2. Quiñones Galvan, A

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

R

  1. Rabaud, M

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

  2. Rabinovitch, A

    • Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes May 1997 46:907-911; doi:10.2337/diabetes.46.5.907

  3. Rasmussen, S K

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

  4. Reece, E A

    • Leptin is present in human cord blood. Diabetes May 1997 46:917-919; doi:10.2337/diabetes.46.5.917

  5. Renström, E

    • Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes May 1997 46:792-800; doi:10.2337/diabetes.46.5.792

  6. Rich, S S

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876
    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  7. Rorsman, P

    • Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes May 1997 46:792-800; doi:10.2337/diabetes.46.5.792

  8. Rothschild, C B

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

S

  1. Sale, M

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  2. Scionti, L

    • Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes May 1997 46:814-823; doi:10.2337/diabetes.46.5.814

  3. Seghieri, G

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  4. Sharma, K

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  5. Sherwin, R S

    • Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes May 1997 46:829-833; doi:10.2337/diabetes.46.5.829

  6. Shigemoto, M

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  7. Shyjan, A W

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  8. Sivan, E

    • Leptin is present in human cord blood. Diabetes May 1997 46:917-919; doi:10.2337/diabetes.46.5.917

  9. Spray, B J

    • Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes May 1997 46:882-886; doi:10.2337/diabetes.46.5.882

  10. Suarez-Pinzon, W L

    • Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes May 1997 46:907-911; doi:10.2337/diabetes.46.5.907

  11. Suga, J

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  12. Sugimoto, T

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

  13. Szabó, C

    • Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes May 1997 46:907-911; doi:10.2337/diabetes.46.5.907

T

  1. Tamsma, J T

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  2. Tardivel, I

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

  3. Tartaglia, L A

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  4. Thomas, M

    • Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes May 1997 46:829-833; doi:10.2337/diabetes.46.5.829

  5. Togawa, M

    • Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes May 1997 46:847-853; doi:10.2337/diabetes.46.5.847

  6. Tonks, P

    • Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes May 1997 46:779-784; doi:10.2337/diabetes.46.5.779

  7. Torffvit, O

    • Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes May 1997 46:868-875; doi:10.2337/diabetes.46.5.868

  8. Trovati, M

    • Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate. Diabetes May 1997 46:742-749; doi:10.2337/diabetes.46.5.742

  9. Trudeau, F

    • Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes May 1997 46:841-846; doi:10.2337/diabetes.46.5.841

U

  1. Urhammer, S A

    • A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes May 1997 46:912-916; doi:10.2337/diabetes.46.5.912

V

  1. van der Woude, F J

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  2. van Det, N F

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  3. Verhagen, N A

    • Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes May 1997 46:834-840; doi:10.2337/diabetes.46.5.834

  4. Vigneau-Hermellin, M

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

  5. Vitali, L

    • Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes May 1997 46:765-769; doi:10.2337/diabetes.46.5.765

W

  1. Warram, J H

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876

  2. Weisberg, L S

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

  3. Weng, X

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

  4. Woolf, E A

    • Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes May 1997 46:900-906; doi:10.2337/diabetes.46.5.900

Y

  1. Yamada, K

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  2. Yamamoto, Y

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  3. Yanagisawa, K

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  4. Yang, Y

    • New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes May 1997 46:876-881; doi:10.2337/diabetes.46.5.876

  5. Yasumura, K

    • Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes May 1997 46:895-899; doi:10.2337/diabetes.46.5.895

  6. Yoshimasa, Y

    • Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes May 1997 46:735-741; doi:10.2337/diabetes.46.5.735

  7. Yoshioka, M

    • A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes May 1997 46:887-894; doi:10.2337/diabetes.46.5.887

Z

  1. Ziyadeh, F N

    • Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes May 1997 46:854-859; doi:10.2337/diabetes.46.5.854

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement